Intraday Price Movement and Trading Activity
During the trading session on 04-Sep, Alivus Life Sciences touched an intraday low of ₹1,363.50, representing a 3.88% decrease from previous levels. The weighted average price indicates that a greater volume of shares traded closer to this lower price point, suggesting selling pressure dominated the session. Despite this, the stock remains well above its 50-day, 100-day, and 200-day moving averages, signalling that the broader trend remains positive. However, it is currently trading below its 5-day and 20-day moving averages, which may reflect short-term weakness or profit-taking by investors.
Investor participation also declined significantly, with delivery volume on 03-Sep falling by 71.81% compared to the five-day average...
Read full news article












